Skip to main content

1Provenance card

the boundary, as counts

Sources

364 with DOI

6 strong · 23 moderate · 7 weak

Compilations

12026-05-09T14:15:18.623Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

28last ruled 2026-06-04

1 awaiting a ruling

Issued documents

42026-10-19T20:32:03.519Z

notice · info card · emergency

Searches

230 with no results

queries and counts on the build

Claims checked

10560 supported

60 supported · 45 not

Correspondence

0received

consent field ships in Phase 4

Edges

309

derivations recorded for this entity

Complete over 36 sources, 1 compilation, and 28 decisions.Not here: the private journal (never); 1 proposal awaiting a ruling (listed as pending only).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/flunitrazepam/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued info_card
  2. 2026-10-02srcSedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank
  3. 2026-10-02srcCharacterization and tentative identification of new flunitrazepam metabolites in authentic human urine specimens
  4. 2026-10-02srcAcute intoxication caused by overdose of flunitrazepam and triazolam: high concentration of metabolites detected at autopsy examination
  5. 2026-10-02srcDrug-facilitated crime: A review of findings between 2019 and 2023
  6. 2026-10-02srcCharacteristics of benzodiazepine abuse in methadone maintenance treatment patients: 1 year prospective study
  7. 2026-10-02srcLack of interaction of buprenorphine with flunitrazepam metabolism
  8. 2026-10-02srcDrug-facilitated sexual assault ('date rape')
  9. 2026-10-02srcCYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam
  10. 2026-10-02srcFlunitrazepam metabolism by cytochrome P450s 2C19 and 3A4
  11. 2026-10-02srcModulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males
  12. 2026-10-02srcViolent behavior, impulsive decision-making, and anterograde amnesia while intoxicated with flunitrazepam and alcohol or other drugs
  13. 2026-10-02srcThe role of cytochrome P450 2C19 activity in flunitrazepam metabolism in vivo
  14. 2026-10-02srcFlunitrazepam-induced changes in neurophysiological, behavioural, and subjective measures used to assess sedation
  15. 2026-10-02srcThe importance of a urine sample in persons intoxicated with flunitrazepam--legal issues in a forensic psychiatric case study of a serial murderer
  16. 2026-10-02srcFlunitrazepam does not alter cerebral distribution of buprenorphine in the rat
  17. 2026-10-02srcRelative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds
  18. 2026-10-02srcDoes high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences
  19. 2026-10-02srcDouble blind comparison of zolpidem 20 mg versus flunitrazepam 2 mg in insomniac in-patients
  20. 2026-10-02srcPharmacokinetics of flunitrazepam following single dose oral administration in liver disease patients compared with healthy volunteers
  21. 2026-10-02srcBioavailability from various galenic formulations of flunitrazepam
  22. 2026-10-02srcEffect of heparin administration on flunitrazepam protein binding
  23. 2026-10-02srcHigh-Dose Benzodiazepine Users' Perceptions and Experiences of Anterograde Amnesia
  24. 2026-10-02srcDrug interactions and clinical pharmacokinetics of flumazenil
  25. 2026-10-02srcAnterograde and retrograde amnesia after lormetazepam and flunitrazepam
  26. 2026-10-02srcFlunitrazepam: a review of its pharmacological properties and therapeutic use
  27. 2026-10-02srcClinical pharmacokinetics of midazolam, flunitrazepam and diazepam
  28. 2026-10-02srcComparative pharmacokinetics of diazepam and flunitrazepam
  29. 2026-10-02srcPrecipitated withdrawal in squirrel monkeys after repeated daily oral administration of alprazolam, diazepam, flunitrazepam or oxazepam.
  30. 2026-10-02srcAnxiolytic drugs: dependence, addiction and abuse
  31. 2026-10-02srcSystemic absorption and abuse liability of snorted flunitrazepam
  32. 2026-10-02srcDeaths involving the benzodiazepine flunitrazepam
  33. 2026-10-02srcA comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers
  34. 2026-10-02srcAbuse liability of flunitrazepam among methadone-maintained patients
  35. 2026-10-02srcRohypnol (Flunitrazepam) DEA Drug Fact Sheet
  36. 2026-10-02srcFlunitrazepam
  37. 2026-10-02srcDrug-Induced Rape Prevention and Punishment Act of 1996 (H.R.4137)
  38. 2026-09-04issueIssued emergency
  39. 2026-09-04issueIssued info_card
  40. 2026-09-04issueIssued notice
  41. 2026-07-03proposaldependence · taper
  42. 2026-06-04proposal25 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  43. 2026-06-04publicationPublication — backfill
  44. 2026-05-09revisionRevision 1
  45. 2026-05-09genGeneration — pipeline-v5 · with 3 morepipeline-v5
  46. 2026-05-09rungeneration run

The same entries, as forms: six forms.